Lotus Bio-Technology Development Corp
Lotus Bio-Technology Development Corp. does not have significant operations. The company intends to seek opportunities in the Organic and Bio-technology space. Previously, it is engaged in refining organic materials, and production of natural consumer related products. The company was formerly known as Starflick.com and changed its name to Lotus Bio-Technology Development Corp. in April 2016. Lot… Read more
Lotus Bio-Technology Development Corp (LBTD) - Total Liabilities
Latest total liabilities as of March 2021: $116.77K USD
Based on the latest financial reports, Lotus Bio-Technology Development Corp (LBTD) has total liabilities worth $116.77K USD as of March 2021.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Lotus Bio-Technology Development Corp - Total Liabilities Trend (2011–2017)
This chart illustrates how Lotus Bio-Technology Development Corp's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Lotus Bio-Technology Development Corp Competitors by Total Liabilities
The table below lists competitors of Lotus Bio-Technology Development Corp ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Chaoprayamahanakorn Public Company Limited
BK:CMC
|
Thailand | ฿4.79 Billion |
|
YX Precious Metals Bhd
KLSE:0250
|
Malaysia | RM41.55 Million |
|
Baosheng Media Group Holdings Ltd
NASDAQ:BAOS
|
USA | $9.23 Million |
|
Dimet (Siam) Public Company Limited
BK:DIMET
|
Thailand | ฿147.09 Million |
|
PT Winner Nusantara Jaya Tbk
JK:WINR
|
Indonesia | Rp107.74 Billion |
|
Augros Cosmetic Packaging SA
PA:AUGR
|
France | €12.18 Million |
|
Onfolio Holdings Inc
NASDAQ:ONFO
|
USA | $4.55 Million |
Liability Composition Analysis (2011–2017)
This chart breaks down Lotus Bio-Technology Development Corp's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.75 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -1.90 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 2.11 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Lotus Bio-Technology Development Corp's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Lotus Bio-Technology Development Corp (2011–2017)
The table below shows the annual total liabilities of Lotus Bio-Technology Development Corp from 2011 to 2017.
| Year | Total Liabilities | Change |
|---|---|---|
| 2017-03-31 | $80.86K | +21.10% |
| 2016-03-31 | $66.77K | +42.95% |
| 2015-03-31 | $46.71K | -10.58% |
| 2014-03-31 | $52.23K | +291.38% |
| 2013-03-31 | $13.35K | -74.24% |
| 2012-03-31 | $51.80K | +43.95% |
| 2011-03-31 | $35.98K | -- |